GMF CBD LINE
DEAD

Serial Number

97062590

Owner

GLOBAL MEDICAL US, LLC

Attorney

Juliet Alcoba

First Use Date

Oct 6, 2021

Filing Date

Oct 6, 2021

Add to watchlist:

No watchlists yet
View on USPTO

GMF CBD LINE Trademark

Serial Number: 97062590

GMF CBD LINE is a trademark filed by GLOBAL MEDICAL US, LLC on October 6, 2021. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

GLOBAL MEDICAL US, LLC (2 trademarks)

8641 NW 112 CT
DORAL, FL 33178

Entity Type: 16

Trademark Details

Filing Date

October 6, 2021

Registration Date

Not Registered

First Use Anywhere

October 6, 2021

First Use in Commerce

October 6, 2021

Goods & Services

Nutritional supplements; Nutritional supplements for pain relief, comprising ingredients derived from industrial hemp seeds solely derived from cannabis with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis; Nutritional supplements in the form of gummies, comprising ingredients derived from industrial hemp seeds solely derived from cannabis with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis; Nutritional supplements in the form of CBD extracts, comprising ingredients derived from industrial hemp seeds solely derived from cannabis with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis; Nutritional supplements in the form of CBD oils, comprising ingredients derived from industrial hemp seeds solely derived from cannabis with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis; Chewing gum for medical purposes; Medicated chewing gum for pain relief, comprising ingredients derived from industrial hemp seeds solely derived from cannabis with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis; Non-medicated, therapeutic skin creams for the treatment of pain, comprising ingredients derived from industrial hemp seeds solely derived from cannabis with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis; Topical analgesic creams

Filing History

ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Jan 23, 2023 MAB2
ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Jan 20, 2023 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Jan 20, 2023 ABN2
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jun 29, 2022 GNRN
NON-FINAL ACTION E-MAILED
Jun 29, 2022 GNRT
NON-FINAL ACTION WRITTEN
Jun 29, 2022 CNRT
ASSIGNED TO EXAMINER
Jun 27, 2022 DOCK
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Feb 3, 2022 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Feb 3, 2022 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Feb 3, 2022 REAP
ASSIGNED TO EXAMINER
Jan 13, 2022 DOCK
ASSIGNED TO EXAMINER
Jan 12, 2022 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 30, 2021 NWOS
NEW APPLICATION ENTERED
Oct 9, 2021 NWAP